• TRIM66: Epigenetic Control of Monogenic Olfactory Receptor E

  2026-07-22

  The reference study identifies TRIM66 as a critical epigenetic repressor governing the monogenic expression of olfactory receptor genes in sensory neurons. By elucidating TRIM66's role in enhancer repression and sensory neuron specificity, the research advances understanding of how neuronal diversity and precise olfactory coding are molecularly achieved.

• E-64d in Translational Research: Mechanisms, Protocols, and

  2026-07-22

  This thought-leadership article unites mechanistic depth with actionable strategies for translational researchers investigating cysteine protease inhibition. It explores how E-64d, a membrane-permeable and irreversible calpain inhibitor, enables rigorous dissection of cell death, neuroprotection, and disease mechanisms, while providing protocol guidance and a critical outlook for research maturity. By bridging foundational knowledge with clinical relevance, and referencing both landmark plant autophagy studies and advanced workflow resources, this article provides a uniquely integrative perspective beyond standard product literature.

• Nascent Cone Precursors as the Origin of Human Retinoblastom

  2026-07-21

  This study reveals that ATOH7+/RXRγ+ nascent cone precursors are the earliest cell-of-origin for human retinoblastoma, using RB1-deficient retinal organoid models. The findings provide a refined cellular framework for understanding tumorigenesis and inform the development of targeted therapies.

• NF 449: Redefining Precision in Platelet Activation Studies

  2026-07-21

  NF 449, a potent and selective purinergic receptor antagonist, is transforming platelet research by enabling unprecedented specificity in dissecting P2X1-mediated pathways. Integrating mechanistic insight and translational strategy, this article explores how NF 449 advances experimental clarity, supports antithrombotic agent research, and sets a new standard for reproducibility in platelet pharmacology.

• Erastin: Precision Ferroptosis Induction in Advanced Cancer

  2026-07-20

  Discover how Erastin, a potent ferroptosis inducer, is transforming cancer biology research by enabling highly selective and mechanistically distinct cell death assays. This article reveals novel insights for experimental design and clinical translation, grounded in the latest peer-reviewed evidence.

• Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG

  2026-07-20

  Phosbind Acrylamide revolutionizes protein phosphorylation analysis by eliminating the need for phospho-specific antibodies and enabling high-resolution separation of phosphorylated proteins within a single gel. Its optimized chemistry delivers clarity and sensitivity for signaling studies, streamlining workflows and advancing translational research.

• Capsaicin in Applied Research: TRPV1 and KDM1A/LSD1 Targetin

  2026-07-19

  Capsaicin ((E)-Capsaicin) is a dual-action molecule, enabling precision research in pain signaling and epigenetic modulation. This article delivers actionable protocols, troubleshooting guidance, and comparative insights for deploying APExBIO's Capsaicin in cellular and animal models, with a focus on gastric cancer and chronic pain applications.

• WP1066: Precision JAK2/STAT3 Inhibition in Cancer and Beyond

  2026-07-18

  Discover how WP1066, a potent JAK2/STAT3 inhibitor, is reshaping cancer and hematologic research. This article delivers a fresh, in-depth analysis of WP1066’s mechanistic profile, translational applications, and unique insights from recent regenerative studies.

• PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration

  2026-07-17

  This study uncovers how endoplasmic reticulum stress (ERS) intensifies pyroptosis and inflammation in nucleus pulposus cells through PERK-dependent JAK1–STAT3 activation. These insights clarify the molecular mechanisms linking ERS to intervertebral disc degeneration and highlight new therapeutic targets to mitigate disc-related inflammation and degeneration.

• Allosteric 5-HT3 Receptor Interactions: Insights from Ginger

  2026-07-17

  This article discusses a computational study that explores how ginger-derived compounds interact with the murine 5-HT3 receptor at both orthosteric and allosteric sites. The findings provide structural insights relevant to antiemetic drug design, including parallels with clinically used 5-HT3 receptor antagonists.

• Nanoparticle Physicochemistry Drives Corneal Uptake Mechanis

  2026-07-16

  Azadi and David’s study systematically dissects how nanoparticle size and surface chemistry dictate cellular uptake by human corneal epithelial cells. Their findings clarify which nanoparticle properties optimize ocular drug delivery, informing the design of advanced, better-targeted ophthalmic formulations.

• FCCP in Mitochondrial Biology: Protocols, Performance & Pitf

  2026-07-16

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) empowers researchers to dissect mitochondrial function, HIF pathway inhibition, and metabolic regulation with unmatched precision. This article demystifies FCCP’s stepwise application, optimization strategies, and troubleshooting, translating robust evidence and recent methodological breakthroughs into actionable laboratory guidance.

• Gap26 Peptide: Strategic Advances in Translational Gap Junct

  2026-07-15

  Explore how Gap26, a validated connexin 43 mimetic peptide, is revolutionizing translational research through precise gap junction modulation. This article synthesizes mechanistic insights, recent experimental breakthroughs, and strategic workflow guidance for vascular, neuroprotection, and pain research—bridging foundational biology with clinical promise.

• Tamoxifen as a Selective Estrogen Receptor Modulator: Advanc

  2026-07-15

  Tamoxifen's versatility as a selective estrogen receptor modulator extends far beyond classic breast cancer research, enabling precise CreER-mediated gene knockout and emerging applications in kinase inhibition and antiviral studies. This guide unpacks validated protocols, advanced troubleshooting, and practical workflow enhancements for maximizing experimental success with APExBIO’s high-purity Tamoxifen.

• Capsaicin (E)-Capsaicin: Dual TRPV1 Activation and KDM1A Inh

  2026-07-14

  Capsaicin is a vanillamide compound acting as a potent TRPV1 ion channel activator and a competitive, reversible inhibitor of KDM1A/LSD1. It mediates pain, itch, and anti-cancer effects in validated cellular and animal models, with mechanistic and protocol clarity from APExBIO and recent peer-reviewed studies.

444 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page